PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation (PRCT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PRCT · as of Jun 9, 2026
Key Statistics
Explore PROCEPT BioRobotics Corporation Data
prct stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 15 · Buy rate: 73.3%
The PRCT analyst consensus is Buy, based on ratings from 15 Wall Street analysts over the past 3 months. The average 12-month price target is $40.25, representing +41.98% upside from the current price of $28.35.
Competitors & Peers
prct competitorsPRCT
AORT
BGM
CLOV
EWTX
GRDNStock Performance
Full HistoryAbout PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation specializes in pioneering surgical robotic technologies, offering innovative solutions within the field of urology. Its flagship product is the AquaBeam Robotic System,…
what is procept biorobotics corporation · prct stock overview · procept biorobotics corporation company profile · who is procept biorobotics corporation ceo · prct NASDAQ · procept biorobotics corporation headquarters · procept biorobotics corporation business segments
About Stock Overview & Key Data
PROCEPT BioRobotics Corporation (PRCT) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Sep 15, 2021. As of the latest trading session, PRCT stock price is $28.35, with a market capitalization of $1.6B. The stock has returned -54.90% over the past 12 months and -9.89% year-to-date.
According to 15 Wall Street analysts, the consensus rating for PROCEPT BioRobotics Corporation stock is Buy, with an average 12-month price target of $40.25. In fiscal year 2025, PROCEPT BioRobotics Corporation reported revenue of $308.1M and net income of -$95.6M. For detailed data — including PROCEPT BioRobotics Corporation revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, PROCEPT BioRobotics Corporation (PRCT) stock price is $28.35. The stock is traded on NASDAQ under the ticker symbol PRCT. The 52-week range is $19.35 – $64.92.